Contineum Therapeutics reported net income of -$15.47M for the quarter ended Jun 2026. This income statement covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 9.11M | 9.11M | 9.11M | 9.11M | 9.11M | 25.72M | 25.73M | 25.85M | 25.87M | 25.90M | 29.18M | 37.32M | 37.34M | 37.47M |
| Revenue & cost | ||||||||||||||
| Revenue | 50.00M | |||||||||||||
| Operating items | ||||||||||||||
| Research & DevelopmentR&D | 3.63M | 9.46M | 6.50M | 8.01M | 7.78M | 7.90M | 9.73M | 13.02M | 13.71M | 14.06M | 10.99M | 12.76M | 11.65M | 12.70M |
| Selling, General & AdministrativeSG&A | 1.48M | 1.60M | 1.57M | 1.66M | 2.15M | 3.04M | 3.25M | 4.03M | 4.40M | 3.84M | 3.94M | 4.36M | 5.26M | 4.73M |
| Operating ExpensesOpex | 5.12M | 11.06M | 8.07M | 9.68M | 9.93M | 10.94M | 12.97M | 17.05M | 18.11M | 17.90M | 14.93M | 17.11M | 16.90M | 17.43M |
| Operating IncomeOp. Inc | -5.12M | 38.94M | -8.07M | -9.68M | -9.93M | -10.94M | -12.97M | -17.05M | -18.11M | -17.90M | -14.93M | -17.11M | -16.90M | -17.43M |
| EBIT | -5.12M | 38.94M | -8.07M | -9.68M | -9.93M | -10.94M | -12.97M | -17.05M | -18.11M | -17.90M | -14.93M | -17.11M | -16.90M | -17.43M |
| Non-operating items | ||||||||||||||
| Non Operating Interest Expenses | 0.09M | 0.12M | ||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.07M | -0.06M | 1.74M | 1.79M | -0.17M | -0.07M | 2.74M | 2.53M | 0.10M | 2.03M | 1.96M | 2.01M | -0.51M | 2.34M |
| Other Non Operating IncomeOther Non Op Inc. | -0.02M | -0.08M | -0.04M | 1.27M | -0.01M | -0.08M | -0.03M | -0.05M | -0.13M | -0.17M | 0.18M | -0.05M | -0.06M | -0.07M |
| Non Operating IncomeNon Op. Inc. | 0.29M | 3.36M | 1.70M | 1.75M | 1.51M | 1.94M | 2.71M | 2.48M | 2.12M | 1.86M | 2.41M | 1.96M | 2.45M | 2.27M |
| Net income details | ||||||||||||||
| EBT | -4.82M | 42.30M | -6.37M | -7.93M | -8.42M | -9.01M | -10.27M | -14.56M | -18.01M | -15.87M | -12.97M | -15.11M | -17.42M | -15.09M |
| Tax ProvisionsTaxes | 0.73M | -0.12M | 4.28M | -8.88M | ||||||||||
| Profit After TaxPAT | -4.82M | 41.56M | -6.28M | -7.58M | -8.42M | -9.01M | -10.27M | -14.60M | -15.99M | -16.06M | -12.80M | -15.18M | -14.46M | -15.47M |
| Income from Continuing OperationsIncome (Continuing) | -4.82M | 41.57M | -6.25M | -12.21M | -8.42M | -9.01M | -10.27M | -5.68M | -18.01M | -15.87M | -12.97M | -15.11M | -17.42M | -15.09M |
| Consolidated Net IncomeConsol Net Inc. | -4.82M | 41.57M | -6.25M | -12.21M | -8.42M | -9.01M | -10.27M | -5.68M | -18.01M | -15.87M | -12.97M | -15.11M | -17.42M | -15.09M |
| Income towards Parent CompanyParent Net Inc | -4.82M | 41.57M | -6.25M | -12.21M | -8.42M | -9.01M | -10.27M | -5.68M | -18.01M | -15.87M | -12.97M | -15.11M | -17.42M | -15.09M |
| Net Income towards Common StockholdersNet Income | -4.82M | 41.57M | -6.25M | -12.21M | -8.42M | -9.01M | -10.27M | -5.68M | -15.99M | -16.04M | -12.79M | -15.11M | -17.42M | -15.09M |
| Additional items | ||||||||||||||
| EPS (Basic) | -2.12 | 18.11 | -2.69 | -5.28 | -3.55 | -0.39 | -0.40 | -0.29 | -0.62 | -0.62 | -0.45 | -0.55 | -0.47 | -0.40 |
| EPS (Diluted) | -2.12 | 11.84 | -2.69 | -3.59 | -3.55 | -0.39 | -0.40 | -0.29 | -0.62 | -0.62 | -0.49 | -0.55 | -0.47 | -0.40 |
| Shares Outstanding | 2.28M | 2.30M | 2.33M | 2.31M | 2.37M | 23.36M | 25.73M | 19.35M | 25.87M | 25.90M | 28.12M | 27.70M | 37.34M | 37.47M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 2.28M | 3.51M | 2.32M | 3.40M | 2.37M | 23.36M | 25.73M | 19.35M | 25.87M | 25.90M | 25.90M | 27.70M | 37.34M | 37.47M |
| EBITDA | -5.12M | 38.94M | -8.07M | -9.68M | -9.93M | -10.94M | -12.97M | -17.05M | -18.11M | -17.90M | -14.93M | -17.11M | -16.90M | -17.43M |
| Interest ExpensesInt Expense | 0.09M | 0.12M | ||||||||||||
| Tax Rate | 1.72 | 1.85 | -53.91 | 61.00 |